On September 18, Hubei Biocause Pharmaceutical hit the limit down, Qitian Technology dropped more than 7%, Jiangxi Tianli Technology, ST Kop, Kaisa Jiayun Technology, and others all dropped more than 3%.
A股互联网保险普跌 天茂集团跌停
The A-share internet insurance market is generally down, with Hubei Biocause Pharmaceutical hitting the lower limit of daily trading.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated